Optimizing cell therapy with spatial biology
Waypoint Bio has raised $20.0M in total funding. The most recent round was Series A. The last funding was announced in May 2026.
Waypoint Bio's investors include General Catalyst, Lux Capital, Village Global, Hummingbird Ventures, Amplify Partners.
Waypoint Bio is headquartered in New York, United States.
Optimizing cell therapy with spatial biology
Waypoint Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Waypoint Bio — Funding & Investors." VCBacked, May 27, 2026, https://www.vcbacked.co/company/waypoint-bio. Accessed July 19, 2026.
VCBacked. (2026). Waypoint Bio — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/waypoint-bio
{{cite web |title=Waypoint Bio — Funding & Investors |url=https://www.vcbacked.co/company/waypoint-bio |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated